Advent Life Sciences Competitors

Baird Capital makes venture capital, growth equity and private equity investments in strategically targeted sectors around the world. We are value creators who identify exceptional opportunities and partner with senior industry executives to build world-class companies. Our in-depth sector knowledge, deep relationships with entrepreneurial management teams and global network of 60 investment and operating professionals in the United States, U.K. and Asia help ensure that we consistently drive value in our portfolio companies. For disclosures please visit: http://www.rwbaird.com/about-baird/important-disclosures.aspx

New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. Founded in 1977, NEA has more than $35 billion in assets under management as of December 31, 2025, and invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of investing includes more than 285 portfolio company public listings and more than 510 mergers and acquisitions. For more information, please visit www.nea.com.

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.